CONTRACEPTION: FROM ANTIQUITY TO THE PRESENT DAY
- Autores: Prilepskaya V.N.1, Mezhevitinova E.A.1, Letunovskaya A.B.1, Ivanova E.V.1, Sasunova R.A.1, Tagieva A.V.1, Prilepskaya VN1, Mezhevitinova Y.A1, Letunovskaya AB1, Ivanova Y.V1, Sasunova RA1, Tagiyeva AV1
-
Afiliações:
- Edição: Nº 13 (2011)
- Páginas: 12-17
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278953
- ID: 278953
Citar
Texto integral
Resumo
Sobre autores
Vera Prilepskaya
Elena Mezhevitinova
Anna Letunovskaya
Elena Ivanova
Rimma Sasunova
Aygyun' Tagieva
V Prilepskaya
Ye Mezhevitinova
A Letunovskaya
Ye Ivanova
R Sasunova
A Tagiyeva
Bibliografia
- Нестеровская И.В., Осипова А.А., Эволюция контрацептивных вагинальных рилизинг-систем // Проблемы репродукции 2007. № 4. C. 59-63.
- Прилепская В.Н., Межевитинова Е.А. Гормональная контрацепция.М., 2011. C. 156-58.
- Ромащенко О.В. История развития женской сексологии // Медицинские аспекты здоровья женщины 2007. № 3. C. 14-16.
- Archer DF, Jensen JT, Johnson JV, et al. Evaluation of a continuous regimen of levonorgestrel/ethinylestradiol: phase 3 study results. Contraception 2006;74:439-45.
- Benagiano G, Bastianelli C, Farris M. Contraception today. Ann NY Acad Sci 2006;1092:1-32.
- Benagiano G, Carrara S, Filippi V. Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives. Pat Pref Adher 2009;3:131-43.
- Cagnacci A, Ferrari S. Evolution and future of contraception. Minerva Ginecol 2010;62(4):303-17.
- Calaf I, Alsina J. After 50 years of ethinylestradiol, another oestrogen in combined oral contraceptives. Eur J Contracept Reprod Health Care 2010;15:1-3.
- Dhont M. History of oral contraception. Eur J Contracept Reprod Health Care 2010;15(2):12-8.
- Diczfalusy E. Gregory Pincus and steroidal contraception. Acta Obstet Scand Suppl 1982;105:7-15.
- Dore DD, Norman H, Loughlin J, et al. Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users. Contraception 2010;81(5):408-13.
- Gupta SK, Gupta N, Suman P, et al. Zona pellucida-based contraceptive vaccines for human and animal utility. J Reprod Immunol 2011;88(2):240-46.
- Hannaford PC, Iversen L, Macfarlane TV, et al. Mortality among contraceptive pill users: Cohort evidence from RoyalCollege of General Practitioners'OralContraception Study. BMJ 2010;340:c927. doi: 10.1136/bmj.c927.
- He YP, Xu WX, Hong AZ, et al. Immunogenic comparison for two different recombinant chimeric peptides (CP12 and CP22) containing one or two copies of three linear B cell epitopes from β-hCG subunit. J Biotechnol 2011;151(1):15-21.
- Kiley J, Hammond C. Combined oral contraceptives: A comprehensive review. Clin Obstet Gynecol 2007;50:868-77.
- Lete I, et al. Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain. Eur J Obstet Gynecol Reprod Biol 2011;154(1):71-80.
- Lidegaard O, Lokkegaard E, Svendsen AL, et al. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009;339:b2890. doi: 10.1136/bmj.b2890.
- Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA2004;291(13):1610-20.
- Reid RL, Westhoff C, Mansour D, et al. Oral contraceptives and venous thromboembolism. Consensus opinion from an international workshop held in Berlin, Germany in December 2009. J Fam Plann Reprod Health Care2010;36:117-22.
- Risk of thromboembolic disease in women taking oral contraceptives. A preliminary communication to the Medical Research Council by a Subcommittee. Br Med J 1967;2:355-9.
- Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update 2006;12:169-78.
- Speroff L, Fritz MA. Clinical Gynecologic Endocrinology and Infertility. 7th edn. Philadelphia, PA, USA: Lippincott Williams& Wilkins 2005:559.
- Speroff L. A good man -Gregory Goodwin Pincus. Portland, Oregon: Arnica Publishing, Inc. 2009.
- Tariq N, et al. Efficacy of levonorgestrel intrauterine system (LNG-IUS) for abnormal uterine bleeding and contraception, J Coll Physicians Surg Pak 2011;21(4):210-13.
- WHO. Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1995;346:1575-82.
- Wiegratz I, Kuhl H. Metabolic and clinical effects of progestogens. Eur J Contracept Reprod Health Care 2006;11:153-61.
- Zakharova MY, et al., Risk Factors for Heart Attack, Stroke, and Venous Thrombosis Associated With Hormonal Contraceptive Use. Clin Appl Thromb Hemost 2010;7. Epub ahead of print.
Arquivos suplementares
![](/img/style/loading.gif)